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Abstract
Background: Protein energy malnutrition (PEM) predisposes individuals to disease, delays recovery from illness and
reduces quality of life. Care home residents in the United Kingdom are especially vulnerable, with an estimated 30
to 42 % at risk. Evidence for nutritional interventions to address PEM in the care home setting is lacking. Widely used
techniques include food-based intervention and/or the use of prescribed oral nutritional supplements. To define
outcomes and optimise the design for an adequately powered definitive trial to compare the efficacy of established
nutritional interventions in this setting, a cluster randomised feasibility trial with a 6-month intervention was undertaken.
Methods: Care home residents with or at risk of malnutrition were identified across six UK care home sites from
September to December 2013. Homes were cluster randomised to standard care (SC), food-based intervention (FB) or
oral nutritional supplement intervention (ONS), for 6 months. Key outcomes were trial feasibility and the acceptability of
design, allocated interventions and outcome assessments. Anthropometry, dietary intake, healthcare resource usage and
participant-reported outcome measures were assessed at baseline and at 3 and 6 months.
Results: All six care homes approached were recruited and retained. Of the 110 residents at risk of malnutrition, 85 %
entered the trial, and 68 % completed the 6-month intervention. Pre-specified success criteria for feasibility were met for
recruitment and retention, intervention acceptability (resident compliance ≥60 %) and measurement of weight, body
mass index (BMI), mid-upper arm circumference and dietary intake (data completeness >80 %). Measurement of handgrip
strength and triceps skinfold thickness was not found to be feasible in this population. The 95 % confidence interval (CI)
data suggested sensitivity to change in dietary intake for weight, BMI and energy intake between baseline and 3 months
when each intervention (FB and ONS) was compared with SC.
Conclusions: A definitive trial comparing the efficacy of nutritional support interventions in increasing weight and BMI in
malnourished care home residents can be conducted. However, whilst the design was feasible, this trial has highlighted
the lack of clinically and patient-relevant outcome measures that are appropriate for use in this setting for both research
and clinical practice. In particular, this trial identified a need for a more simple measure of functional status, which
considers the limitations of functional tests in the care home population.
Trial registration: Current Controlled Trials ISRCTN38047922, Date assigned: 22 April 2014.
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Background
Often under-recognised and under-treated, protein energy
malnutrition (PEM) develops when energy intake and/or
protein intake chronically fail to meet the body’s nutritional
requirements [1]. It can affect virtually every function and
organ system of the human body [2], predisposing individ-
uals to disease and delaying recovery from illness [3]. In the
UK, more than 1 million people over the age of 65 are mal-
nourished or at risk of PEM, and the vast majority (93 %)
are residents in a community setting. In 2007, the health
and social care costs associated with malnutrition were esti-
mated to exceed £13 billion annually, more than 10 % of
the public expenditure on health care [4].
Care homes are arguably home to one of the UK’s most
vulnerable populations [5], 30 % to 42 % of whom are esti-
mated to be at risk of malnutrition [6]. PEM significantly im-
pacts the physical and emotional well-being of care home
residents and has been linked to increased vulnerability to in-
fection and pressure ulcers, clinical complications, depression
and decreased quality of life [7–9]. Evidence for nutritional
strategies to address malnutrition in the care home setting is
lacking [10]. Widely used dietetic techniques to enhance oral
dietary intakes in care homes include food-based interven-
tion (recipe enrichment or fortification of conventional food
to increase energy and/or protein density, provision of nour-
ishing snacks and/or fortified drinks) and/or the use of pre-
scribed oral nutritional supplements (ONS) [11], considered
to be ‘dietary foods for special medical purposes’ (FSMPs)
[12]. The British Dietetic Association (BDA) and The
National Prescribing Centre (NPC) advocate improving
dietary intake first using fortification of conventional food
and secondly by prescribed means [13, 14] However, few
trials have evaluated the food-based approach, and whether
this type of intervention is able to improve clinical outcomes
for malnourished individuals remains unclear [10, 15, 16].
The use of conventional food-based intervention is
considered more economical to the National Health
Service (NHS) in England than prescribed ONS. In 2011,
ONS incurred an annual cost of £105 million, a 10 %
increase from 2010. Many General Practitioner (GP) prac-
tices identified the significant and increasing costs of ONS
at this time, often accompanied by prolonged and in-
appropriate prescribing. Medicines Management teams
subsequently imposed stricter prescribing guidance and
encouraged greater use of conventional food-based inter-
vention before or in place of prescribed intervention [17].
However, the development of initiatives to reduce ONS
usage prompted concerns about delayed appropriate pre-
scribing [18]. A number of individual components make
up complex healthcare interventions such as nutritional
support in the care home setting, making it difficult to
specify the ‘active ingredient’ of the intervention and to
compare intervention variations [19] Whilst there may be
potential to improve oral dietary intake in a variety of
ways and by using interventions in combination, it is im-
portant to establish the effectiveness of both conventional
food-based and prescribed ONS interventions to ensure
that the most appropriate nutrition support is initiated
promptly for vulnerable individuals to minimise further
deterioration in nutritional status.
Existing Systematic reviews of nutritional interventions
for PEM [20–23] have tended to focus on the effectiveness
of ONS compared with placebo or standard care and have
been predominantly conducted within the acute setting. A
Cochrane meta-analysis, which evaluated the effectiveness
of ONS in malnourished older adults [23] reported a small
but consistent weight gain with ONS, but the inclusion of
primary outcomes of relevance to patients, such as func-
tional measures and quality of life, were lacking, whilst
severely malnourished individuals were frequently ex-
cluded for ethical reasons. A Cochrane systematic review
and meta-analysis was the first to evaluate the impact of
dietary advice and/or food-based intervention on PEM
[10]. The evidence from the review suggests that dietary ad-
vice and intervention for PEM may improve weight and in-
dicators of muscle mass, with or without ONS, but the
findings are not specific to the older adult population.
Whereas most of the included trials provided information
on the duration of the intervention, there was almost no in-
formation on the nature, intensity and content of the food-
based interventions. The review also highlighted a complete
lack of evidence for the effects of food-based intervention
on patient-reported outcome measures (PROMs), which
are an important determinant of intervention effectiveness.
No systematic review to date has made any specific con-
clusions regarding nutritional interventions for the treat-
ment of PEM in the care home setting. There is a tendency
to avoid research in care homes because of the methodo-
logical issues involved [24], and the majority of epidemio-
logical studies either exclude care home residents at the
outset or fail to follow up participants when they move into
institutional care [25]. The challenges inherent in care
home research has led to nutritional intervention trials in
this setting that have excluded those with advanced de-
mentia or immobility [16, 26–28], despite these being
well-established risk factors for malnutrition. As a result,
knowledge of the actual effectiveness of the dietetic inter-
ventions for malnutrition that are currently used with this
vulnerable population is limited and the clinical applicabil-
ity of findings to those residents most at risk is often ques-
tionable. The lack of evidence to support best practice
provides an opportunity to bring new ideas to the field.
To enable the efficacy of these widely used dietetic
interventions to be compared within the care home
population, an adequately powered randomised controlled
trial (RCT) is required. In light of the lack of adequately
powered trials with a low risk of bias that have evaluated
nutrition support interventions within the care home
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setting, a feasibility trial was proposed prior to the initi-
ation of a definitive RCT. In this feasibility trial, the
research aim was to explore trial design, staff and resident
acceptability of the interventions and outcome measures
and to provide data to estimate the parameters required
to design a definitive RCT.
Methods
This feasibility trial has been reported with reference to
the CONSORT guidelines [29] [Additional file 1].
Trial design
The trial was conducted in 2013–2014 as a prospective
cluster randomised feasibility trial. Three arms were
assessed: food-based (FB) intervention, ONS interven-
tion and the standard care (SC) home diet for malnutri-
tion with 6-month intervention duration. Six care home
sites were randomised into the three trial arms.
Trial objectives
The primary objectives of the trial were as follows:
1. To assess how many care homes accepted the
invitation to participate in research.
2. To determine whether the eligibility criteria for care
home residents were too open or too restrictive by
estimating feasible eligibility and recruitment rate.
3. To assess retention of care homes and residents by
estimating 3 and 6-month follow-up rates.
4. To investigate the acceptability of nutritional support
interventions to malnourished care home residents in
terms of compliance and to care home staff in terms
of adherence to the intervention schedule.
5. To assess the acceptability and feasibility (and
factors influencing this) of the outcome measures as
methods to measure efficacy of the interventions
within a definitive trial.
The secondary objectives of the trial were as follows:
1. To investigate the completion of screening tools and
questionnaires by care home staff.
2. To determine how many malnourished residents
were able to participate in PROMs and to complete
the questionnaires.
3. To pilot a Healthcare resource usage (HCRU)
questionnaire.
4. To measure key outcome domains (for completion
rates, missing data, estimates, variances and 95 %
confidence intervals for the difference between the
intervention arms) for malnourished care home
residents, including physical outcome measures and
PROMs.
5. To collect and synthesise data, from which the
Intracluster Correlation Coefficient (ICC) and
sample size of a definitive cluster RCT (CRCT)
could be estimated.
Ethical considerations and research governance
The trial was approved by the West Midlands NHS
Local Research Ethics Committee and the Research and
Development Department of the Heart of England NHS
Foundation Trust prior to commencement. The trial
was registered at www.isrctn.com (Current Controlled
Trials ISRCTN38047922). The REC approved the con-
sent, randomisation and intervention taking place at the
care home level. However, the committee felt that the
inclusion of residents lacking capacity in the collection
of PROMs could not be justified in accordance with the
Mental Capacity Act [31]. They requested that those
residents having capacity to complete PROMs,
provide individual consent for this part. A joint Data
Monitoring Committee/Trial Steering Committee,
which included three independent members (a statis-
tician; a dietitian and a member of a patient and
public involvement panel), was established prior to
trial commencement (August 2013). The DMC/TSC
met in January, April and July 2014 to review AEs,
mortality and intervention changes. A final meeting
was held in November 2014 to discuss the trial
findings and inform the evaluation.
Study settings
The feasibility trial was conducted within the borough
of Solihull, West Midlands, in England. Prior to trial
commencement, the care and catering staff in 17 care
homes providing accommodation for older adults
(over 65 years) were receiving regular dietetic input
to improve the first-line management of malnutrition.
Six, privately owned care homes, selected by purpos-
ive sampling to obtain a diverse sample based on type
of care provided (residential or nursing/nursing and
residential) were invited to take part in the trial.
None of the care homes had previously been involved
in any research.
Participants
Recruitment began in September 2013 and concluded in
December 2013.
– Care homes (clusters)
Prospective participating care homes were provided
with an information sheet and a full explanation of the
trial by the Primary Researcher, a registered dietitian with
a history of clinical input in all six homes. Each care home
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was given 1 week to consider participating, after which,
the manager was asked to sign a consent form.
– Care home residents
All residents at risk of malnutrition and without a
dietetic-led plan in place were considered for eligibility
within participating care homes. Care home staff with
responsibility for conducting monthly nutritional screen-
ing, used the Malnutrition Universal Screening Tool
(‘MUST’) to identify those at risk of malnutrition.
‘MUST’ classifies risk as low, medium or high based on
body mass index (BMI), history of unintentional weight
loss (%) and acute illness effect [11, 30]. ‘MUST’ has
been validated for use in adults, has very good-to-
excellent inter-observer reliability in care homes (kappa
0.8 to 1.0) and is acceptable to participants and health-
care workers [30]. The REC requested that assessment
of eligibility be carried out by non-research staff. Care
home staff reviewed the records of those residents iden-
tified as being at medium or high risk of malnutrition
against the eligibility criteria.
Inclusion criteria for residents were as follows:
1. A score of ‘1’ or higher on the ‘MUST’,
2. Able to eat and drink, and
3. Registered with a Solihull GP and subsequently
eligible for the provision of healthcare services
provided by the Heart of England NHS foundation
Trust (HEFT).
Exclusion criteria for residents were as follows:
1. Receiving (or likely to receive in the next 6 months)
enteral tube feeding or parenteral nutrition;
2. Receiving nutritional support in the form of dietetic
advice or prescribed ONS;
3. Have a known eating disorder or illness, which
requires a therapeutic diet incompatible with
fortification and/or supplementation; or
4. On an end-of-life care pathway.
Exclusion criteria for Participant Reported Outcome
Measures (PROMs) include the following:
1. Non-native English speaking or
2. Lacking the capacity to consent.
In accordance with the requirements of the approving
Research Ethics Committee (REC), residents lacking the
capacity to consent were excluded from taking part in
PROMs. The decision to exclude non-native English
speaking residents, with or without capacity, was based
on the Primary Researcher’s existing knowledge of the
population group and consideration of the finances avail-
able to run the trial. The Primary Researcher estimated
that fewer than 5 % of the resident population would be
non-native English speaking. This trial was conducted as
part of a student MRes project and as such, had no
additional funding attached to it. This prohibited the
translation of information leaflets into different languages
and the hire of an interpreter.
Individual resident consent for PROMs
Within the care home setting, capacity is assessed by
trained care home staff or the GP in accordance with
the Mental Capacity Act [31]. Written consent was
sought on an individual basis from eligible residents
assessed as having functional capacity. Residents were
provided with a full explanation of their required partici-
pation alongside a Participant Information Sheet. Each
resident was asked to sign a consent form
The interventions
Food-based intervention (FB) in addition to standard care (SC)
The content of the FB intervention choices was based
on local nutrition support guidelines and national guid-
ance and resources for best practice [11, 32, 33]. These
types of interventions are widely recommended by dieti-
tians in clinical practice and are based on ingredients
that are commonly used in this setting. Care staff and
catering teams in the two homes randomised to FB
intervention, received face-to-face instruction from the
Primary Researcher to increase the participating resi-
dent’s daily nutritional intake by approximately 600 kcal
and 20 to 25 g of protein. The choices presented
(Table 1) were discussed in relation to the preferences of
the resident and the resources and time available at the
home. The agreed intervention combination was docu-
mented for each resident, at baseline and at 3 months,
and recipes were provided. The method of estimating
resident food intake being used in all six care homes was
the assessment of mealtime servings as a whole, followed
by the assignment of a proportion consumed. Staff were
asked to continue using this method to record the time
of intervention provision and resident intake on the daily
food record chart (FRC) as a proportion taken (All; ¾;
½; ¼; refused).
ONS intervention in addition to standard care (SC)
Nursing and/or senior care staff in the two homes
allocated to the ONS intervention received instruction
by the Primary Researcher to increase the daily nutri-
tional intake of participating residents by approximately
600 kcal and 24 g protein. In accordance with local nu-
trition support guidelines, the intervention consisted of
two liquid ONS (Table 1), provided to residents under
the control of a registered dietitian. Staff were asked to
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record the time of the intervention provision and resi-
dent intake on the daily drugs chart as a proportion
taken (All; ¾; ½; ¼; refused).
The Primary Researcher determined resident compli-
ance with the FB and ONS interventions at 3 and
6 months by calculating average intake from three non-
consecutive FRCs or drugs charts. Local nutrition
support guidelines advise a minimum first-line ONS pre-
scription of two servings daily. However, the clinical
benefits of ONS (unknown for FB intervention) have
been seen with one to three servings (300 to 900 kcal)
daily [11, 34]. To inform the acceptability of the interven-
tion dose used in this trial, compliance was categorised
into ‘non-compliant’, if <50 % (300 kcal) of the advised
food/beverage or ONS was consumed daily, compliant
with 50 % to 75 % (300 to 450 kcal) of the advised food/
beverage/ONS and compliant with 75 % to 100 % (450 to
600 kcal) of the advised food/beverage/ONS. Staff
adherence with the intervention schedule was also deter-
mined at 3 and 6 months through the collection and re-
view of three non-consecutive FRCs and drugs charts.
Adherence was recorded as a percentage of residents that
were provided with the agreed intervention type at the
agreed frequency of provision.
Standard care
All six care homes recruited into the trial had received
training and support to provide an SC intervention to
residents with or at risk of malnutrition, and all six were
considered to be providing adequate standard care. The
purpose of a care home SC intervention is to provide a
calorie-dense diet [35] through the provision of small,
frequent, energy-enriched meals in a ‘family-style’ dining
room designed to improve the social ambience around
mealtimes. Prompting and assistance is provided by staff
where required. SC was provided in all six care homes to
Table 1 Food-based and ONS intervention composition
Intervention Recipe Volume per
serving (ml)
Energy content (kcal)
per serving
Protein content (g)
per serving
Approximate cost
per serving
Food-based intervention options To the care home
Fruit fool 300 ml fruit puree, 150 g custard, 2 tbsp milk
powder, 150 ml evaporated milk, 1 tbsp Honey
(makes 3)
200 275 7.9 70p
Chocolate mousse 1 sachet instant chocolate dessert, 4 tbsp milk
powder, 150 ml double cream, 150 ml full
cream milk (makes 2)
150 410 10.95 65p
Milkshake 200 ml full cream milk, 1 tbsp milk powder, 1
tbsp double cream, milkshake powder to taste
200 306 9.8 70p
Fruit smoothie 200 ml full cream milk, 2 tbsp milk powder, 3
tbsp double cream, 1 ripe banana/other fruit,
30 g ice cream
200 306 10 80p
Milky coffee 200 ml full cream milk, 1 tbsp milk powder, 1
heaped tsp of coffee granules, 2 tbsp double
cream
200 278 10.6 75p
Malted drink 200 ml full cream milk, 1 tbsp milk powder, 1
tbsp double cream, malted powder (Horlicks/
ovaltine or equivalent) to taste
200 304 12 65p
Hot chocolate 200 ml full cream milk, 1 tbsp milk powder, 1
tbsp double cream, drinking chocolate powder
to taste
200 306 10.6 65p
ONS intervention options To the GP practice
Fortisip Bottle
(Nutricia Advanced
Medical Nutrition)
200 300 12 £2.06
Fortisip Compact
(Nutricia Advanced
Medical Nutrition)
125 300 12 £2.02
Nutriplen (Nualtra Ltd) 125 300 12 £1.45
The nutritional content of the FB recipes was analysed by the Primary Researcher using the nutritional software package, Diet Plan 6
Fortisip bottle and Fortisip compact are manufactured by Nutricia Advanced Medical Nutrition and were provided by Nutricia for use within the first 3 months of
the intervention duration. Nutriplen is manufactured by Nualtra Ltd and was provided by Nualtra for the second 3 months of the intervention duration. The ONS
did not incur a cost to the care home GP practice in this trial but would do so within usual care
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ensure that no resident at risk of malnutrition was
denied access to first-line treatment [36]. The two care
homes allocated to SC only continued to receive visits
from the Primary Researcher, but individualised resident
plans were not provided.
The Primary Researcher continued to make dietetic
visits to all six care homes on a monthly basis. If a resident
did not tolerate the allocated intervention (SC, FB or
ONS) or experienced a significant decline in nutritional
status, a change in nutritional intervention was considered
in accordance with local guidelines. Intervention change
was recorded for all three trial arms at 3 and 6 months.
Measures
Demographic variables and resident characteristics:
Following confirmation of eligibility, care home staff
recorded data for each resident on gender, primary diag-
nosis, capacity, height and diagnosis of dementia and
dysphagia. With usual standard care, if measurement of
height with a freestanding stadiometer was not possible,
the staff in all six homes had been trained to ask resi-
dents or relatives for self-reported height or to use ulna
length to estimate height from the length of the forearm
in accordance with ‘MUST’ [30].
Outcome measures
One trial objective was to evaluate feasibility and accept-
ability of a range of outcome measurements, to establish
those most appropriate for a definitive trial. Data complete-
ness of ≥80 % was required for an outcome to be consid-
ered for a definitive trial [37]. The primary researcher and
the care home staff were responsible for assessment of par-
ticipating residents (Table 2). To enhance the quality and
consistency of staff-assessed outcomes, a training session
led by the Primary Researcher was provided, consisting of:
1. Training on the protocols surrounding assessment
and recording of outcome measurements
2. Discussion on adverse events and their reporting
3. Mock completion of data collection instruments and
form
4. Weight and Body Mass Index (BMI).
Care homes are required to weigh residents on class
III approved calibrated scales and to calculate their BMI
at least monthly to promote adequate monitoring of
nutritional status [38]. Weight and BMI were collected
from the care home ‘MUST’ records, along with the
number and proportion of residents that could or could
not be weighed and the type of scale used. At 3 and
6 months, the primary researcher calculated a repeat
‘MUST’ score for two randomly selected residents per
care home and compared the overall score and the
scores for each step with that recorded by staff. This en-
abled competence in calculating BMI and malnutrition
risk to be assessed.
– Mid-upper arm circumference (MUAC) and triceps
skinfold thickness (TSF)
MUAC, an estimate of subcutaneous fat and arm
muscle [39], has been established as a useful indicator of
malnutrition risk [40, 41]. TSF is reflective of subcutane-
ous fat mass and distribution [39] and can be used
alongside MUAC to evaluate body composition and to
assess nutritional status [42]. The Primary Researcher
measured MUAC with a tape measure and TSF with a
Slimguide calliper (HaB Essentials), according to stan-
dardised procedures. Where possible, the mean of three
measurements was recorded to minimise measurement
error [43]. The number of residents that refused to have
the measurements undertaken, or for whom measurement
Table 2 Assessment Schedule
Measure Completed by Assessment Time
Baseline 3 months 6 months
Nutritional Intake Primary Researcher √ √ √
Weight Care home staff √ √ √
BMI Care home staff √ √ √
Handgrip Strength Primary Researcher √ √ √
MUAC Primary Researcher √ √ √
TSF Primary Researcher √ √ √
VAS Participant rated √ √ √
EQ-5D Participant rated √ √ √
CO-OP QoL Participant rated √ √ √
Healthcare resource usage Care home Staff √ √
BMI body mass index, MUAC mid-upper arm circumference, TSF tricep skinfold thickness, VAS visual analogue scale, EQ-5D Euroqol 5 dimensions, QoL quality
of life
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was not possible, was recorded. MUAC and TSF were
used to calculate mid-arm muscle circumference
(MAMC), an indicator of protein stores and an estimate
of lean muscle mass.
– Handgrip strength
Handgrip strength an index of general upper
extremity strength, is strongly associated with
functionalit [44]. Handgrip strength was measured
using the Smedley hand held dynamometer
(Model 12-0286) on the nondominant arm. Where
possible, residents were asked to complete the
measurement 3 times on the dominant arm. Due
to varying levels of cognitive impairment, it was
felt that resident understanding of how to
undertake the measure would be poor initially, but
improve during the process. The highest achieved
measure was therefore recorded. The number of
residents that refused to participate, or for whom
the measurement was not feasible, was recorded.
– Nutritional Intake Assessment
To ensure compliance with Outcome 5 (Meeting
nutritional needs) of the Essential Standards of
Quality and Safety [37], care home staff are
required to complete daily food record charts
(FRCs) and fluid charts (FCs), to monitor the
dietary intake of those with, or at risk of
malnutrition. The primary researcher measured
and recorded the size/capacity of usual tableware
within each care home, at baseline.At each data
collection interval, the FRCs and FCs were used to
assess the average daily food and fluid intake over
three nonconsecutive days. The primary
researcher determined daily energy (kcal) and
protein (g) intake using the dietary analysis
software, Diet Plan 6 (Forestfield Software Ltd,
UK). The number of unavailable or incomplete
FRCs and FCs was recorded for each care home.
– Healthcare resource usage
Healthcare resource usage data is used alongside
health outcomes data to calculate the Incremental
Cost-effectiveness Ratio (ICER) [45], defined as the ratio
of the difference in cost, to the difference in effectiveness
between two intervention strategies. The healthcare
resource-usage questionnaire piloted for feasibility by the
care home staff in this trial was developed from consider-
ation of existing instruments submitted for use in residen-
tial care settings on the ‘MRC Database of Instruments for
Resource Use Measurement’ (DIRUM). The questionnaire
collected information on hospital admissions, GP call-outs
and visits from district nurses, dietitians and Speech and
Language Therapists (SaLT).
Patient-reported outcome measures (PROMs)
Eligible residents that had provided individual informed
consent were provided with the following questionnaires
by care home staff.
– Health state: EQ5D-5 L
A core component of economic evaluations in health-
care is the use of preference-based instruments to meas-
ure changes in health state. The EuroQol-5D (ED5D-5 L)
questionnaire, a standardised, multi-dimensional health
state classification [46] consists of a Visual Analogue Scale
(VAS), which records self-perceived health status on a
scale of 0 to 100 and a descriptive system comprising five
dimensions of health (mobility, self-care, usual activities,
pain/discomfort and anxiety/depression). The descriptive
system can be used to generate a single index value for
health state [47], scored in this trial using an algorithm
based on a sample from the adult UK population [48].
– Appetite and dietary satisfaction: A Visual Analogue
Scale (VAS)
Measured food intake appears to be related to the
perceptions of hunger and fullness that can be assessed
using a VAS [49, 50]. In this trial a 100 mm VAS was
developed to pilot the measurement of each of the fol-
lowing in this setting: ‘hunger’, ‘appetite’, ‘dietary satisfac-
tion’, ‘pleasantness of meals’, ‘pleasantness of snacks’ and
‘pleasantness of drinks’.
– Quality of Life: COOP
Quality of life was assessed using the Dartmouth
COOP Quality of life chart, a brief, easy-to-complete
questionnaire that is sensitive to subjectively important
change [51]. The COOP has been validated in general
primary care settings [52] and was piloted in this trial
with a care home population.
Sample size
No formal sample size calculation was performed because
the key outcomes were concerned with recruitment,
retention and the feasibility and acceptability of the trial
[53]. Any investigations of changes in study parameters
were exploratory only. Based on the capacity of the
selected care homes (29 to 72 residents) and the risk of
malnutrition in the UK care home population (30–42 %),
it was estimated that between nine (30 % of 29) and 30
(42 % of 72) residents could be considered for receipt of
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the nutritional intervention within each care home. It was
decided that this estimated sample size of n = 50 (6 × 9) to
n = 180 (6 × 30) would provide sufficient data to assess
trial feasibility [54].
Cluster randomisation
A cluster design was chosen primarily to avoid contam-
ination [55] because the care home staff at each site
could not be expected to treat participating residents
differently.
Sequence generation
The random allocation sequence was generated using a
computer-generated random number list at the University
of Birmingham Clinical Trials Unit. To minimise the time
delay between care homes agreeing to participate and
implementation of the interventions, care homes were
randomised once eligible residents had been identified.
This approach is recognised as a means of overcoming
delays between recruitment and intervention implementa-
tion in cluster trials and was felt to be particularly relevant
with the frail, care home population [56].
Allocation concealment and mechanism
Concealment of intervention allocation was achieved by
giving responsibility for sequence generation and alloca-
tion to a statistician independent of the running of the
trial. Completing the screening and consent process
prior to sequence generation minimised selection bias,
thereby ensuring that decisions were not influenced by
the assigned intervention.
Implementation
The Primary Researcher provided the statistician with the
list of care homes that had consented. The statistician
stratified and matched clusters according to care type (one
nursing and one residential home per pair) and then con-
secutively numbered all matched pairs. The random alloca-
tion sequence was generated, and pairs were assigned to
intervention allocation. The statistician notified the primary
researcher of the allocations, and each care home was then
informed. Staff within each site received training from the
primary researcher to support delivery of the allocated
intervention and/or a refresher on SC.
Blinding
Residents were recruited prior to random allocation of
care homes to the three arms. As consent was sought at
the care home level (aside from PROMs), individual
residents were not told of the care home intervention
assignment. If a resident questioned the different drink
or snack provided, they were told it had been ordered by
the dietitian and would be good for them.
Due to the nature of the interventions and the obvious
differences between them, it was not possible to blind
the staff delivering them. However, nutritional interven-
tions often involve contextual factors that cannot be sepa-
rated from the intervention itself, such as who delivered
the intervention, assistance provided and the setting. It is
also acknowledged that the SC trial arm also involved
delivery of nutrition support, which may have minimised
the differences in resident treatment between trial arms.
This trial had one Primary Researcher, responsible for
communicating intervention allocation to participating
homes and conducting outcome assessments. It was
therefore impossible to blind the primary researcher to
the assigned intervention. To minimise bias, the chosen
outcome measures were objective and not easily influ-
enced by the observer. In a definitive trial with funding
for additional research staff, it should be possible to use
observers who assess outcome measures without know-
ledge of the intervention group.
Statistical methods
Statistical analyses were performed using IBM SPSS,
version 21.
Because effective hypothesis testing requires a pow-
ered sample size [53], analysis was limited to descriptive
statistics and an exploratory analysis to provide estimates
of key parameters and inform the design of a definitive
trial. Baseline categorical variables were summarised using
proportions, n ( %). All continuous baseline data were
tested for normality using Kolmogmorov-Smirnov and
were summarised as mean (standard deviation (SD)) or
median (interquartile range (IQR)).
Screening logs completed in each care home provided
information on the numbers of residents screened using
‘MUST’ and the reasons for not entering the trial. These
data, alongside categorical data collected on care home and
resident withdrawals, changes to resident intervention, mor-
tality, healthcare resource usage, adverse events and compli-
ance, were summarised (n ( %)) and used to inform aspects
of feasibility and acceptability reporting. Continuous out-
come measures were summarised as means (SD) or medians
(IQR) at 3 and 6 months and mean changes were calculated
from baseline to 3 months and 6 months, along with 95 %
confidence intervals. The mean difference between ONS and
SC and FB and SC were calculated at 3 and 6 months, along
with 95 % confidence intervals. This data was used to review
the sensitivity of the outcome measures to the change in
dietary intake and inform which outcome measures are most
appropriate to take forward into a definitive trial.
The intracluster correlation coefficient (ICC)
To determine the optimal sample size for a definitive
cluster RCT, calculations will be required, which involve
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the number of clusters, the number of individuals within
clusters and the power, significance level and effect size
being sought [57]. As the residents in a care home are
more likely to be similar, the variability of treatment
effects within clusters and the power to detect true dif-
ferences between intervention arms is reduced [19]. To
account for this, an estimate of the magnitude of the
intracluster correlation coefficient (ICC), which com-
pares within-group variance to between-group variance
[58] will be required for the primary outcome measure
to be taken forward. To determine the most appropriate
primary outcome for a definitive trial, completion rates
and missing data were summarised for all outcome mea-
sures, along with estimates and variances.
Assessment of feasibility and acceptability
A priori, it was specified that the five primary trial objec-
tives would be considered successful if the pre-specified
success criteria were met (Table 3).
The broader methodological framework of the trial
To address fully the research question and trial objec-
tives, a sequential, explanatory mixed method design
was chosen [59], but due to time constraints, it was not
realistic to transcribe and analyse the qualitative data
within the scope of the MRes project. A mixed methods
framework was felt to be necessary to provide a compre-
hensive analysis of the feasibility and acceptability issues
associated with delivering and evaluating nutritional
interventions in the care home setting. The use of inter-
views and focus groups in a qualitative phase would
enable the feasibility outcomes to be further explored
with the trial participants, ensuring that resident and
staff perspectives can be used to inform design and con-
duct for a definitive trial. The qualitative methodology
has not been reported on in this manuscript but will be
analysed and reported on separately.
Results
Study population: Loss and exclusions
All six care homes approached consented to participate
in the trial within the 3-month care home recruitment
period (September 2013 to December 2013). All 280
residents living across the six care homes were screened
using ‘MUST’, and 110 (39 %) were at medium or high
risk of malnutrition. Of the 110 residents, 93 (84.5 %)
were eligible to enter the trial and receive the interven-
tion [see Additional file 2]. Reasons for the remaining 17
residents not entering the trial were that they were
already receiving dietetic-led nutrition support (n = 13),
in the hospital (n = 2), not registered with a Solihull GP
(n = 1) and non-English speaking (n = 1). Of the 93 resi-
dents deemed eligible to enter the trial, only 16 (17 %)
were determined by care home staff to have the capacity
to consent to PROMs. Written informed consent was
obtained from 11 residents, three declined, one was too
unwell to be approached and one declined due to family
influence. Of the 32 residents in the care homes assigned
to SC, two moved out, and 11 died within 6 months. Of
the 32 residents in the care homes assigned to FB inter-
vention, two entered end-of-life care, one moved out,
and six died. Of the 29 residents in the care homes
assigned to ONS intervention, one moved out, one was
admitted to the hospital and six died. A total of 63 resi-
dents completed the trial by the end of June 2014 and
were included in the analyses.
Baseline data
Demographic data and resident clinical characteristics
are shown in Table 4. Included residents were mostly fe-
male (82 %), with dementia being the most prominent
primary diagnosis (75 %). SC, FB and ONS residents
were similar with respect to gender, capacity and diagno-
sis at baseline. It was considered useful to consider
imbalances at baseline within this feasibility trial of few
clusters (n = 6) to inform the sample size for a definitive
trial. There was a noted difference in the proportion of
residents at medium and high risk of malnutrition in the
care home assigned to the FB intervention (34 % high risk
compared to >60 % for the other two arms). The mean
values for weight (kg), energy intake (kcal) and fluid intake
(ml) were also higher for the FB residents than the resi-
dents in the care homes allocated to SC and ONS.
Outcomes: assessment of feasibility and acceptability
The assessment of the pre-specified success criteria is
summarised in Table 5
Retention
All six care homes completed the trial. Of the 93 residents
that entered the trial, 67 (72 %) remained at month 3 and
63 (68 %) completed the 6-month intervention. In total,
23 residents died during the trial (25 % mortality), 17
(74 %) of whom were at high risk of malnutrition and 6
(26 %) at medium risk of malnutrition. Of those 23, 87 %
died during the first 3 months. Other reasons for loss to
follow-up included residents moving out (n = 4), entering
end-of-life care (n = 2) and being admitted to hospital with
no planned return (n = 1).
Acceptability of the allocated interventions
Compliance with the dietetic-led interventions (FB and
ONS) was determined at 3 and 6 months. The propor-
tion of fully compliant residents reduced from 74 % at
3 months to 67 % by 6 months, although 86 % of resi-
dents during both phases consumed at least half of the
provided amount (≥300 kcal) of either FB or ONS inter-
vention. Residents assigned to the FB intervention had
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greater compliance compared with ONS at both
3 months (78 % versus 67 %) and 6 months (70 % versus
63 %). Reasons for noncompliance were refusal of the
intervention (n = 4), poor overall intake including the
intervention (n = 6) and crossover to a different inter-
vention (n = 1).
At 3 months, staff adherence to the intervention sched-
ule was 100 % for both ONS and FB intervention. At
6 months, staff adherence with the FB intervention sched-
ule was 100 % and staff adherence to the ONS interven-
tion schedule was 95 %. Drug chart documentation and
discussions with staff, revealed that one resident in CH01
was not consistently provided with the agreed upon ONS
dose.
Acceptability and feasibility of the outcome measures
– Weight
At baseline, seven residents (8 %) were weighed
with standing scales, 63 (70 %) with chair scales and
19 (21 %) with hoist scales. Only one resident was
Table 3 Feasibility and acceptability success criteria
Objectives: Success criteria
Recruitment of care homes • Recruitment target of six met in the time available (3 months)
Resident eligibility criteria and recruitment • Favourable difference shown in number at risk of malnutrition
and number that were deemed eligible (≤20 % difference)
• Estimated resident recruitment target of n ≥50 met
Retention of care homes and residents • Retention of 100 % for care home sites
• Retention of ≥65 % for residents at 6 months follow-up,
accounting for expected high mortality and attrition rates
Intervention acceptability to residents and staff • Intervention crossover of ≤10 % for each trial arm
• Given that the clinical benefits of ONS (unknown for FB) are
seen with one to three servings (300 to 900 kcal) daily:
- ≥80 % of residents to be compliant with ≥50 % dietetic-led
intervention dose (≥300 to 450 kcal),
- ≥60 % of residents to be compliant with ≥75 % of the
dietetic-led intervention dose (≥450 to 600 kcal)
• ≥85 % staff adherence to intervention schedule
Feasibility and acceptability of the outcomes piloted • Data completeness of≥ 80 %
• Reported and recorded values were considered complete.
Unknown and blank values (due to lack of recording, resident
refusal, and inability to measure) were considered missing values.
Objectives: Success criteria
Recruitment of care homes • Recruitment target of six met in the time available (3 months)
Resident eligibility criteria and recruitment • Favourable difference shown in number at risk of malnutrition
and number that were deemed eligible (≤20 % difference)
• Estimated resident recruitment target of n ≥50 met
Retention of care homes and residents • Retention of 100 % for care home sites
• Retention of ≥65 % for residents at 6 months follow-up,
accounting for expected high mortality and attrition rates
Intervention acceptability to residents and staff • Intervention crossover of ≤10 % for each trial arm
• Given that the clinical benefits of ONS (unknown for FB) are
seen with one to three servings (300 to 900 kcal) daily:
- ≥80 % of residents to be compliant with ≥50 % dietetic-led
intervention dose (≥300 to 450 kcal),
- ≥60 % of residents to be compliant with ≥75 % of the
dietetic-led intervention dose (≥450 to 600 kcal)
• ≥85 % staff adherence to intervention schedule
Feasibility and acceptability of the outcomes piloted • Data completeness of≥ 80 %
• Reported and recorded values were considered complete.
Unknown and blank values (due to lack of recording, resident
refusal, inability to measure) were considered missing values.
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Table 4 Demographic and clinical characteristics of residents at baseline (n = 93)
SC (n = 32) FB (n = 32) ONS (n = 29)
Gender
Male 5 6 6
Female 27 26 23
Capacity 5 4 7
Diagnosed dementia 25 25 20
Diagnosed dysphagia 7 4 7
Risk of re-feeding 3 0 4
Malnutrition risk
High risk 20 11 19
Medium risk 12 20 9
Weight (kg)* Weighed (n = 31) Weighed (n = 32) Weighed (n = 29)
48.6 (9.1) 55.9 (1.8) 48.2 (10.9)
BMI (kg/m2)** 19 (17.0-20.5) 20.1 (18.7-24.8) 18.4 (17.6-21.6)
MAC (cm) Measured (n = 27) Measured (n = 28) Measured (n = 25)
21.9 (2.7) 23 (2.5) 22 (3.0)
TSF (mm)* Measured (n = 24) Measured (n = 22) Measured (n = 23)
9.3 (2.8) 13.2 (5.6) 8.4 (3.1)
MAMC (cm)* n = 24 n = 22 n = 23
18.9 (2.5) 18.9 (1.7) 18.5 (2.5)
HGD (kg)** Measured (n = 14) Measured (n = 22) Measured (n = 13)
5.65 (3.9-8.3) 6.9 (4.0-11.5) 5.6 (3.2-10.3)
Energy Intake (kcal)* Available (n = 29) Available (n = 31) Available (n = 27)
1553 (470) 1916 (496) 1535 (562)
Protein Intake (g)* Available (n = 29) Available (n = 31) Available (n = 27)
41 (14.6) 78 (22) 54 (20)
Fluid Intake (ml)* Available (n = 27) Available (n = 31) Available (n = 27)
1109 (237) 1332 (310) 1037 (260)
COOP QoL score** n = 3 n = 2 n = 6
5 (5–7) 4 (2–6) 5.5 (4–6)
EQ5D VAS* n = 3 n = 2 n = 6
53 (16) 70 (28) 61 (21)
EQ5D index value* n = 3 n = 2 n = 6
−0.16 (0.38) 0.15 (0.28) 0.33 (0.33)
Hunger* n = 3 n = 2 n = 6
4 (3) 5 (7) 4 (4)
Appetite* n = 3 n = 2 n = 6
6 (4) 5.5 (6) 5 (4)
Dietary Satisfaction* n = 3 n = 2 n = 6
9 (0.6) 8.5 (2) 8.5 (2)
Pleasantness of meals* n = 3 n = 2 n = 6
9 (1) 6 (4) 6 (3)
Pleasantness of snacks* n = 3 n = 2 n = 6
7(1.5) 8(1.4) 6(4)
Stow et al. Trials  (2015) 16:433 Page 11 of 21
unable to be weighed, and that was due to a decline
in clinical condition. At 3 months, one resident,
weighed by chair scales at baseline, was weighed
using hoist scales because of reduced mobility. All
other residents in the trial were weighed using the
same scales throughout.
– MUAC, TSF and Handgrip strength
Over the three data collection intervals, 88 % of the
residents had MUAC measured, 76 % had TSF measured
and 54 % had HGD measured. It was not always the
same residents that declined or were unable to take part
in the measurements. This fluctuation in ability and will-
ingness to participate may be a consequence of the high
number of residents with cognitive impairment.
– Nutritional intake
Over the three data collection intervals, 81 % of the
FRCs and 87 % of the FCs were available and complete,
but despite the training provided to the care homes
within usual dietetic practice and prior to trial initiation,
there were some limitations to this method of informa-
tion collection. Whilst the care home staff indicated how
much of a meal or snack had been consumed by the
resident as a proportion (All, ¾, ½, ¼, refused), there
was little to no information on what part of the meal
had been eaten, on the recipes used or on specifying
whether ingredients had been added to enrich the
calorie content. This may have reduced the accuracy of
the subsequent dietary analysis and estimation of daily
energy, protein and fluid intake.
Outcomes: Assessment of secondary objectives
– Staff completion of ‘MUST’ tool
Table 4 Demographic and clinical characteristics of residents at baseline (n = 93) (Continued)
Pleasantness of drinks** n = 3 n = 2 n = 6
9(8–10) 9(9–9) 10(8–10)
SC standard care, FB food-based, ONS oral nutritional supplements, QoL quality of life, VAS visual analogue scale. The number of residents included is indicated for
each characteristic *Mean (standard deviation) **Median (interquartile range). EQ-5D index value ranges from −0.59 to 1, with higher scores corresponding to a
better health state. COOP score ranges from 1 to 10, with higher scores corresponding to a better QoL
Table 5 Assessment of feasibility and acceptability success criteria
Objectives Success criteria Met/not met
1. Recruitment of care homes: Met
• Six care homes recruited within 3 months
2. Resident eligibility criteria and recruitment Met
• 84.5 % of those at risk of malnutrition were
eligible for the intervention
• 93 residents recruited
3. Retention of care homes and residents Met
• 100 % of the care homes were retained
• 68 % of the residents were retained at 6 months
4. Intervention acceptability to residents and staff Met
• Intervention crossover of 7.4 % for SC, 4.3 % for ONS
arm and 0 % for FB
• 86 % of residents compliant with ≥50 % of dietetic-led
intervention dose at T1 and T2
• Resident compliance with ≥75 % of the dietetic-led intervention
dose at T1 and T2: FB: 78 % and 70 %; ONS: 67 % and 63 %
• Staff adherence: 100 % for FB at T1 and T2. 100 % for ONS at T1
and 95 % at T2
5. Feasibility and acceptability of the outcomes piloted Met for
• Weight, BMI, MUAC, Energy, protein, fluid intake (>80 % data
completeness)
Not met for
• HGD and TSF (completeness of 54 % and 78 % respectively)
SC standard care, FB food-based, ONS oral nutritional supplements, BMI body mass index, MAC mid-upper arm circumference, TSF tricep skinfold thickness, HgD
handgrip dynamometer, T1 Baseline - 3 months, T2 3 months - 6 months
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At 3 and 6 months, the primary researcher calculated a
repeat ‘MUST’ score for two randomly selected residents
per care home (n = 12). At 3 months, 11 ‘MUST’ scores
had been calculated correctly (92 %). Step two (uninten-
tional weight loss) had been calculated over 1 month, rather
than 3 to 6 months for one resident. At 6 months, all 12
records (100 %) detailed a correctly calculated score.
– Participant-reported outcome measures (PROMs):
All eligible residents were provided with the question-
naires by care home staff at baseline (n = 11), at 3 months
(n = 8) and at 6 months (n = 7), and 100 % of the ques-
tionnaires were completed in full. All residents required
the care home staff to read the questionnaires to them
(due to poor eyesight) and to mark on their responses
(due to poor dexterity). Due to the lack of available data,
there will be no further analysis reported herein, but
resident and staff perceptions of the questionnaires and
the perceived ease or difficulty of taking part in PROMs
have been explored further within a qualitative phase
and will be reported separately.
– Healthcare resource usage questionnaire
The questionnaires were completed in full by care home
staff for 100 % of the residents in the trial at both 3 and
6 months. A total of 24 hospital admissions were recorded
for 16 residents during the trial. Admissions to A&E
accounted for 46 % of the recorded admissions and the
majority were for falls (82 %). A total of 117 GP call-outs
were recorded for 54 residents during the trial. The most
frequently recorded reasons for call-outs were chest exami-
nations (suspected chest infection) (26 %), medication
reviews (19 %) and urinary tract infections (15.4 %). District
Nurse Visits (63 for 16 residents) were usually scheduled to
deliver wound care (37 %) and to check pressure areas
(49 %). The number of recorded District Nurse visits was
notably higher in the three residential homes, where regular
visits were arranged to replace the nursing duties con-
ducted by staff in the care homes providing nursing care.
The staff did not directly attribute any admissions, GP
or District Nurse visits to a decline in a resident’s
nutritional status or to the allocated intervention.
– Data to inform calculation of the intraclass
correlation coefficient (ICC) for a definitive trial
In order to conduct a well-designed definitive trial with
the aim of comparing efficacy of nutritional interventions,
the ICC should be known beforehand to estimate required
sample size and statistical power to reduce the chances of
type II error [60]. The ICC can be used to determine the
increase in variance due to clustering, referred to as the
Design Effect (DE), which varies for each outcome meas-
ure [61]. Further searching of the existing literature and
further piloting within the older adult care home popula-
tion is required first so as to identify the most appropriate
primary outcome measure for a definitive trial and to esti-
mate the population variance of the outcome. The desired
power and significance level can be used alongside the an-
ticipated difference between means (effect size), estimated
from the literature and pilot work, to calculate the size of
the sample that would be required if no clustering was
present. The calculated DE can then be used to estimate
the necessary inflation of the sample size (compared to
that calculated for an individually randomised trial) to
take account of the similarities in the clustered data:
Change in outcomes
To inform which outcome measures are most appropri-
ate to take forwards to a definitive trial, the sensitivity of
the outcome measures to the change in oral dietary
intake on the introduction of nutritional interventions
was assessed by comparing the mean change in outcomes
between the intervention arms at 3 and 6 months. Table 6
shows the intervention effects on physical and nutritional
outcome measures by T1 (3 months). Where the 95 %
confidence interval (CI) of the mean difference (MD) does
not cross zero, sensitivity of the outcome measures to
a change in oral dietary intake and a difference be-
tween the trial arms is suggested. This is observed for
weight, BMI and energy intake when each of the
intervention arms (net increase in these outcomes) is
compared with the SC arm (net decrease) but is not
observed when the FB and ONS intervention arms
are compared.
Table 7 shows the intervention effects on physical out-
come measures and nutrient intake by T2. There remains
a difference in the change in energy intake between each
of the intervention arms (net increase in energy intake)
and the SC arm (net decrease in energy intake) from base-
line to 6 months (T2). As with T1, this was not observed
when the FB and ONS intervention arms were compared.
The mean change in kcal from baseline to 6 months is less
than the added intervention for both of the dietetic-led
intervention arms, suggesting that not all of the residents
were compliant with the interventions, and some may
have reduced their intake of other foods and drinks. The
mean change in weight and in BMI over the full 6-month
intervention was negative in the SC arm, compared with
positive change in each of the dietetic-led intervention
arms. However, the 95 % CI crossed zero for each com-
parison, which suggests that these outcomes were less
sensitive to the change in oral dietary intake at T2 com-
pared to T1.
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Harms
Three adverse events were recorded by care home
staff during the trial. Details of the adverse events
were reduced BMI, placing residents at risk of refeed-
ing syndrome (n = 1 SC and n =1 FB) and poorly
controlled blood glucose levels, reportedly exacerbated
by ONS intake (n = 1 ONS). One resident with re-
duced BMI (FB arm) was undergoing investigations
led by the GP into possible underlying clinical rea-
sons for ongoing involuntary weight loss. The other
two residents were changed to the FB intervention
arm.
Discussion
The feasibility trial design was feasible to undertake in
the care home setting. With commitment from staff and
management, it was possible to obtain consent from six
care homes and to identify 93 residents who were
eligible to receive the allocated interventions, meeting
the recruitment targets for homes and residents. The
success criteria for the retention of care homes and resi-
dents throughout the trial were also met; however, resi-
dent mortality was high, particularly during the initial
3 months. The three nutritional interventions were con-
sidered acceptable to care home residents and staff on
the basis of low crossover rates, satisfaction of the suc-
cess criteria for resident compliance and high staff ad-
herence to the intervention schedules. Of the outcome
measures piloted, weight, BMI, MAC and nutritional
intake were found to be feasible and acceptable mea-
surements to undertake in this population, meeting the
success criteria for data completeness and consideration
for use within a definitive trial. Although the trial was
not powered to examine intervention outcomes, the dir-
ection of effect for weight, BMI and energy intake was in
favour of the FB and ONS interventions, highlighting
sensitivity to a change in oral dietary intake for these
outcome measures.
The following discussion reviews the key findings of the
trial in terms of the feasibility and acceptability objectives.
Table 6 Intervention effects on anthropometric indicators and nutrient intake from baseline to 3 months (n = 67)
Outcome SC (n = 19) FB (n = 27) ONS (n = 21) SC versus FB SC versus ONS FB versus ONS
(MD) [95 % CI] (MD) [95 % CI] (MD) [95 % CI]
Weight change (kg) Weighed (n = 19) Weighed (n = 27) Weighed (n = 21) −1.9 [−3.6, −0.23] −2.3 [−4.3, −0.40] −0.4 [−1.9, 1.1]
−1.5 (3.3) 0.42 (2.4) 0.82 (2.7)
BMI change (kg/m2) −0.55 (1.2) 0.16 (1.0) 0.33 (1.2) −0.7 [−1.4, −0.06] −0.88 [−1.65,
−0.11]
−0.17 [−0.79, 0.44]
MAC change (cm) Measured(n = 13) Measured (n = 24) Measured(n = 18) −0.77 [−1.7, 0.14] −0.67 [−1.9, 0.57]
−1.06 (1.5) −0.29 (1.2) −0.39 (1.8)
TSF change (mm) Measured(n = 11) Measured (n = 19) Measured(n = 15) 1.15 [−0.26, 2.6] −0.77 [−2.9, 1.38]
0.86 (1.5) −0.29 (2.0) 1.6 (3.6)
MAMC change n = 10 n = 19 n = 16 −1.17 [−2.2, −0.14] −0.71 [−1.44, 0.02]
−1.36 (0.8) −0.18 (1.5) −0.65 (0.9)
HgD change (kg) Measured (n = 7) Measured (n = 17) Measured (n = 6) 0.97 [−1.9, 3.9] 1.62 [−1.34, 4.65]
0.16 (2.4) −0.82 (3.4) −1.5 (2.5)
Change in energy intake
(kcal)
Available(n = 18) Available (n = 27) Available(n = 21) −380 [−550, −226] −479 [−697, −263] −99 [−281, 83]
−103 (275) 277 (250) 376 (375)
Change in protein intake
(g)
Available(n = 18) Available (n = 27) Available(n = 21) −2.3 [−8.9, 4.3] −16 [−226, −9.4]
0.72 (6.5) 3 (12.9) 16.7 (12.5)
Change in fluid intake
(ml)
Available(n = 18) Available (n = 27) Available(n = 21) Mann–
Whitney
Mann–
Whitney
400 (100–500)* 100 (−20 - 400)* 250 (112.5 - 250)* U = 164** U = 110**
MD mean difference, SC standard care, FB food-based, ONS oral nutritional supplements, BMI body mass index, MAC mid-upper arm circumference, TSF tricep skinfold
thickness, MAMCmid-arm muscle circumference, HgD handgrip dynamometer
Normal data is presented as Mean change (standard deviation), otherwise is Median change (interquartile range) (indicated by *). The mean difference (MD)
between each dietetic-led intervention arm (FB and ONS) and the SC arm has been calculated for normal data alongside 95 % confidence intervals (CIs), otherwise
the Mann–Whitney U Test (indicated by **) has been used. Where sensitivity to change is suggested by the CI, the MD between the FB and ONS arms has then
been calculated (final column)
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Recruitment and retention
All six care homes provided written consent and remained
in the trial until completion. Prior to trial commencement,
the Primary Researcher had established good working
relationships with the care home managers and staff
within a clinical role. This existing rapport may have been
central to successful recruitment and in enabling specific
roles to be allocated to staff during the trial process. In a
definitive trial, it may be necessary to build in time for
researcher visits to potential care homes to establish trust
and good communication prior to starting recruitment.
MUST’ screening across the six care homes identified
110 residents (39 %) at risk of malnutrition, a similar
percentage to that reported within another care home
nutritional intervention trial conducted in Hampshire
(37 %) [62]. A total of 84.5 % of those at risk met the
eligibility criteria to enter the trial, enabling the recruit-
ment target to be met and supporting the case for a
definitive trial in this setting. A large proportion (75 %)
of the eligible population presented with a primary diag-
nosis of dementia. The decision was made to include
residents with dementia in order to assess feasibility and
acceptability of the trial design with a representative care
home population. Assessment of resident characteristics
at baseline highlighted imbalances between the interven-
tion arms and indicates a need to recruit a large number
of care homes within a definitive trial to increase the like-
lihood of producing balance across cluster-level covariates.
The minimum number of clusters recommended per arm
to ensure statistical validity is at least 4 [63].
Despite the fragility of the participating population, it
was possible to complete follow-up on 68 % of the resi-
dents, thereby achieving the retention target at 6 months.
Mortality was the primary reason for residents leaving
the trial (23 of 93 in 6 months, 25 %) and appeared to
be associated with ‘MUST’ risk category (17 of 23 were
high risk, 74 %). Of the 23 residents that passed away,
20 (87 %) had died by month 3, suggesting that at least a
proportion may have been nearing end-of-life at recruit-
ment. Although being on an end-of-life care pathway
was defined as an exclusion criteria, the restrictions
imposed by the approving REC required care home staff
to assess resident eligibility and those responsible may
have found it challenging to distinguish between residents
Table 7 Intervention effects on anthropometric indicators and nutrient intake from baseline to 6 months (n = 63)
Outcome SC (n = 19) FB (n = 23) ONS (n = 21) SC versus FB SC versus ONS FB versus ONS
(MD) [95 % CI] (MD) [95 % CI] (MD) [95 % CI]
Weight change (kg) Weighed (n = 19) Weighed (n = 23) Weighed n = 21) −1.4 [−3.6, 0.73] −1.4 [−3.3, 0.51]
−0.57 (3.5) 0.87 (3.4) 0.84 (2.5)
BMI change (kg/m2) −0.16 (1.3) 0.33 (1.3) 0.34 (1.1) −0.49 [−1.3, 0.35] −0.50 [−1.3, 0.27]
MAC change (cm) Measured(n = 13) Measured (n = 19) Measured(n = 1) −0.67 [−1.68, 0.34] −0.82 [−2.2, 0.59]
−0.96 (1.6) −0.29 (1.2) −0.14 (2.1)
TSF change (mm) Measured(n = 11) Measured (n = 16) Measured(n = 1) 0.03 [−2.2, 2.26] −0.97 [−3.8, 1.86]
0.68 (2.6) 0.66 (2.9) 1.65 (4.0)
MAMC change n = 11 n = 15 n = 14 −0.68 [−1.58, 0.22] −0.71 [−1.90, 0.33]
−1.08 (1.1) −0.40 (1.1) −0.29 (1.5)
HgD change (kg) Measured (n = 6) Measured (n = 11) Measured(n = 6) 2.2 [−0.50, 4.9] 2.2 [−0.61, 4.9]
1.8 (2.2) −0.42 (2.6) −0.35 (2.1)
Change in energy intake
(kcal)
Available(n = 17) Available (n = 23) Available(n = 2) −255 [−401, −109] −400 [−577, −223] −145 [−319,29.1]
−50.9 (183) 204 (251) 349 (319)
Change in protein intake
(g)
Available(n = 17) Available (n = 23) Available(n = 2) Mann–Whitney Mann–Whitney
1.0 (−3.5 - 4.5) 3.0 (−10 - 6) 9.0 (2–26.5) U = 175 U = 68.5
Change in fluid intake
(ml)
Available(n = 17) Available (n = 23) Available(n = 2) −79 [−219, 60.9] −104 [−242, 34.5]
120 (223) 199 (210) 224 (196)
MD mean difference, SC standard care, FB food-based, ONS oral nutritional supplements, BMI body mass index, MAC mid-upper arm circumference, TSF tricep skin-
fold thickness, MAMC mid-arm muscle circumference, HgD handgrip dynamometer
Normal data is presented as Mean change (standard deviation), otherwise is Median change (interquartile range) (indicated by *). The mean difference (MD)
between each dietetic-led intervention arm (FB and ONS) and the SC arm has been calculated for normal data alongside 95 % confidence intervals (CIs), otherwise
the Mann–Whitney U Test (indicated by **) has been used. Where sensitivity to change is suggested by the CI, the MD between the FB and ONS arms has then
been calculated (final column)
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that may benefit from nutritional intervention and those
that were end-stage palliative. In a definitive trial, not sub-
ject to the same ethical restrictions, dietetic assessment
using a validated method, such as, The Subjective Global
Assessment (SGA) [64] could be considered following
‘MUST’ screening to identify where malnutrition is an in-
dication of end-stage disease, as opposed to an indication
of inadequate nutritional intake that may respond to
intervention.
Acceptability of the interventions
The small percentage of crossover and adverse events
overall (<10 %), suggests that all three interventions
were largely acceptable to residents and to staff monitor-
ing nutritional status. The feasibility success criteria for
compliance were met, with over 60 % of the residents
assigned to FB and to ONS compliant with 450 to
600 kcal/day and over 80 % compliant with at least 300
to 450 kcal/day. Compliance with FB was higher than
ONS at 3 and 6 months, perhaps due to the greater var-
iety and flexibility offered by this intervention.
A systematic review conducted in 2012 identified 46
studies of ONS intervention (nine in the care home set-
ting), which included compliance data. Greater compli-
ance was noted with reduced volume, energy-dense
ONS (1.5 to 2 kcal/ml) and when a variety of flavours
was offered [65], both of which are reported in clinical
practice. In this feasibility trial, the ONS were supplied
free of charge by two medical nutrition companies, and
the bottle size and flavours delivered were dictated by
availability. In a fully funded definitive trial, ONS compli-
ance may be improved by specifying use of the 1.5 kcal/ml
ONS bottles and by offering residents a choice of flavours.
Further qualitative work being undertaken aims to explore
the influence of resident and care staff attitudes to FB and
ONS intervention on compliance.
Acceptability and feasibility of the outcome measures
and data collection methods
In order to ensure clinical applicability, it was decided
that as much data as possible should be collected using
methods consistent with usual procedures. Height was
collected from ‘MUST’ records for 100 % of residents at
baseline. The measurement techniques used had been
clearly documented. The majority had been measured
using a freestanding stadiometer (66 %), but where this
was not possible, estimation by ulna length was the most
frequently used alternative measure (31 %). Surrogate
methods of height estimation are required for those who
are bedridden, confined to a wheelchair or unable to
stand straight. The documented use of the technique
highlights the importance of training on nutritional as-
sessment prior to research or within clinical practice to in-
crease the efficiency and completeness of documentation.
Measured body weight and calculated BMI were
collected from ‘MUST’ documentation at the three data
collection intervals. Just one resident had not been
weighed at baseline, following a decline in clinical condi-
tion and a decision by staff that weighing would be an
unnecessary burden. It was possible to retrieve the
required information for the remaining 92 residents at
baseline and 100 % of the residents remaining at 3 and
6 months. Throughout the trial, only one resident was
weighed using different types of scale, justified by the
staff, in terms of reduced mobility at the 3-month interval.
The success criteria for weight and BMI were achieved, in-
dicating that assessment is acceptable to the majority of
residents and is feasible for staff to undertake.
The most widely used method of estimating resident
food intake was already being used in all six homes; the
assessment of mealtime servings as a whole, following
which a proportion consumed is assigned. The majority
of FRCs and FCs were available and complete, meeting
the success criteria for data completeness. However, lim-
itations relating to the usefulness of the data were ob-
served. Studies that have evaluated the accuracy of care
home staff documentation of dietary intake have shown
it to be erroneous when compared to independent
assessments made by research staff [66, 67]. In this trial,
the Primary Researcher did not have capacity to observe
resident food and fluid intake and in a definitive trial,
intake assessment by research staff would risk losing an
important element of testing interventions in the ‘real
world’ setting. Improvements in the accuracy of recording
could be made by taking photographs of the plate before
and after mealtimes. A validation study [66] found this
method to be reliable and time-efficient and a possible
solution for increasing the accuracy of estimation.
MUAC is included in the ‘MUST’ as an alternative
measure for BMI. The MUAC assessment was found to
be acceptable to the majority of residents (88 %), enabling
the success criteria to be met. A recent cross-sectional
care home study, which compared two observers in-
dependently assessing MUAC on three occasions over
an 8-day period found no systematic differences between
observers and concluded that MUAC is acceptable for
clinical use in a care home setting [68]. Training and use
of a standardised protocol would, however, be essential to
ensure accurate and appropriate measurements are under-
taken by different observers in a definitive trial.
An average of 76 % of residents in the trial had TSF
measured, narrowly missing the success criteria for data
completeness. A number of challenges were encountered
during measuring, including difficulties encouraging resi-
dents to be still, inappropriate positioning of bedridden
residents and anxiety in relation to the visual perception
of the calliper. This experience suggests that it may prove
challenging to accurately perform the measurement in a
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population with fluctuating capacity and challenging be-
haviours. Primary problems associated with the TSF meas-
urement include measurement error due to poor
technique and substantial differences when measurements
are made on the same individual by different observers
[69]. These sources of error are likely to be emphasised in
the care home population, limiting potential use in a de-
finitive trial.
Handgrip strength is the technique most often recom-
mended for measurement of muscle strength and assess-
ment of muscle function in clinical practice [70]. Only
54 % of residents in this trial were able to undertake the
test, and therefore, the success criterion for data com-
pleteness was not met. Cognitive impairments made it
difficult for residents to understand and follow the
instructions, and physical limitations meant some resi-
dents were unable to attempt the measure. This is a
similar outcome to that noted within other trials con-
ducted in the care home setting where no residents were
excluded on the basis of cognitive or physical impair-
ment [71, 72]. These findings suggest that handgrip
strength, in its current form, does not enable assessment
of muscle strength in the general care home population.
There is a requirement for new measurement outcomes
for use in a UK care home setting for elderly with func-
tional impairments.
In the absence of any nutrition-specific measures of
quality-of-life or health state, this trial assessed the feasi-
bility and acceptability of existing generic tools (EQ5D
and COOP), alongside piloting of a VAS to assess appe-
tite and dietary satisfaction. The low numbers recruited
significantly reduced the data available to assess feasibil-
ity and acceptability, and because the tools were not
evaluated with those lacking capacity, the proportion of
residents that may be able to respond in a definitive trial
remains unknown. The perceived importance and bur-
den of taking part in PROMs, alongside the opinions of
staff and residents in relation to whether others could
have taken part, have been explored within the qualita-
tive phase of the trial and will be reported on elsewhere.
Healthcare resource usage
In the absence of a standardised HCRU questionnaire for
malnutrition, the questionnaire piloted in this trial was
designed to collect information on healthcare professional
visits and hospital admissions. Care home staff completed
100 % of the questionnaires at 3 and 6 months, obtaining
all of the required data from resident care records and GP
visit logs. The questionnaire was able to collect useful data
on hospital admissions and professional visits not delivered
in-house (dietitian, speech and language therapist), but the
data on district nurse and GP visits was likely influenced by
the type of care being funded. To enable the questionnaire
to be used to inform an economic evaluation of the
interventions in a definitive trial, thorough staff training
would be required regarding the need to document GP
call-outs only. The limitations with the collection of data
on nursing visits could be addressed by focusing instead on
the reasons for residents requiring nursing care.
The majority of hospital admissions were due to falls,
a high proportion of GP call-outs were for assessment or
treatment of suspected infections, and the majority of
district nurse visits were related to pressure sore care.
Neither the care home staff nor the GP attributed any
admissions or visits to a resident’s malnourished status,
perhaps indicating that awareness of the wide-ranging
consequences of malnutrition [18] is limited. It is pro-
posed that the average cost of treating an infection
(chest or UTI) or a pressure sore could be used along-
side the frequency of occurrence to inform the economic
evaluation of the interventions, reducing the reliance on
GP or district nurse visit data. Further piloting would be
required initially to establish the accessibility and reli-
ability of the necessary data in the care home setting.
Change in outcomes
For estimated energy (kcal) intake, positive changes
favouring the dietetic-led intervention arms were observed
at 3 and 6 months, but there was no difference noted
between the FB and ONS intervention arms. Increase in
total energy intake has been demonstrated in a number of
care home malnutrition intervention trials using both FB
[15, 73–75] and ONS [27, 62, 73] intervention, which sug-
gests that residents increase their overall energy intake
when specific calorie-dense interventions are provided to
them on a daily basis. Improved nutritional intake is
understood to be a key component in the causal pathway
leading to improved clinical outcomes. Change in energy
and protein intake should be included within a definitive
trial as secondary outcome measures, to examine this rela-
tionship further. More accurate means of reporting intake
would enable use alongside compliance data, to determine
whether habitual intake changes to compensate for the
introduction of an intervention.
For recorded weight and BMI, positive changes favour-
ing the dietetic-led interventions were observed when
each intervention was compared with SC at 3 and
6 months. Again, there was no observed difference
between the FB and ONS arms. An increase in weight
and BMI has been reported in a number of care home
malnutrition intervention trials using both FB [76, 77]
and ONS [26–28] [78, 79] intervention. Whilst such
findings suggest these outcomes are sensitive to positive
changes in dietary intake, the composition of weight gain
is unknown. In terms of delivering functional benefit, a
gain of fat mass will not result in improved muscle strength
[23]. The limitations associated with weight and BMI as
outcomes of clinical relevance has led to calls for more
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focus on improvement in functional status or quality of life
as primary trial outcomes. However, weight and BMI con-
tinue to be used in clinical practice as the primary outcome
measures for nutrition support interventions.
Negative change was observed for MUAC and MAMC
over the 6-month intervention in all three arms, whilst
positive change was observed for TSF. Whilst this
suggests that weight gain may have been primarily due
to an increase in fat mass, observed trends should not
be overemphasised due to the feasibility nature of the
trial and the lack of complete data for these outcomes.
In older adults, low MAMC, a measure of arm muscle
area, has been shown to have greater association with
mortality than low BMI [80]. Unfortunately, determining
MAMC requires TSF measurement and additional cal-
culation, which can hamper practical implementation.
The challenges faced within this feasibility trial when
attempting to accurately measure TSF suggests that
skinfold measurement and therefore, also MAMC, are
not appropriate for monitoring short-term changes in
body composition, particularly with a population where
accurate measurement may be hampered.
Limitations
The care homes recruited into this trial do not necessarily
represent the national care home population. All six had
received long-term, regular input from the local dietetic
team and were enrolled in a rolling program of staff train-
ing. The Primary Researcher had an excellent rapport
established with the managers and staff, which may have
made it easier to recruit all of the approached sites, to
conduct the trial within the required timeframes and to
encourage staff to adhere to the protocol. Evaluation of
feasibility was undertaken in interested and motivated care
homes; thus the transferability of the findings would be
dependent upon tailoring to the local context.
Limitations relating to the usefulness of the data from
the collected FRCs and FCs were observed, but whilst
this may have reduced the accuracy of the estimation of
food intake in this trial, it was useful in highlighting that
this commonly used method of intake recording may
reduce the accuracy of estimated nutritional intake in
usual clinical practice. Photographs taken before and
after a meal could enable comparisons within a definitive
trial to be made in a more accurate manner that does
not rely on staff memory. In routine care, the intro-
duction of mealtime photographs alongside staff train-
ing and role delegation could be used to estimate
nutritional intake and to form important evidence
during a CQC inspection.
The restrictions imposed by the approving REC led
to limitations in the conduct of the trial. The absence
of clinical dietetic assessment following ‘MUST’
screening may have resulted in a number of end-stage
palliative care home residents entering the trial and re-
ceiving interventions, which were unlikely to deliver
nutritional benefit. This lack of expert assessment may
have contributed to the high mortality rate during the
first 3 months of the trial, reducing the observed
effectiveness of the interventions and increasing the
risk of attrition bias. Limitations in the design of the
trial also increased the risk of performance and detec-
tion bias through a lack of double blinding. Whilst the
nature of the nutritional interventions under investiga-
tion makes it impossible to blind the care home staff
to treatment allocation, it should be possible in a fully-
funded definitive trial for research staff measuring
outcomes and collecting data to be blinded to the
allocated intervention.
Conclusions
The data presented enable several conclusions to be
drawn that address the research question and trial
objectives. The trial design was feasible to undertake in
the care home setting. The established relationships
between the Primary Researcher and each of the care
home sites may have improved the willingness of staff
to follow the trial protocol. Whilst this was explored
further during the qualitative phase of the trial (to be
reported separately), it is likely that researcher visits to
establish trust and to deliver training will need to be
accounted for in the timeframe of a definitive trial to
aid with successful recruitment of care homes and resi-
dents and to culture good relationships with staff teams.
This trial demonstrated that a definitive trial comparing
the efficacy of FB, ONS and SC interventions in increasing
weight and BMI in malnourished care home residents is
both feasible and acceptable to undertake. Such a trial
could provide useful information as to whether continued
NHS expenditure on prescribed ONS is warranted in this
setting.
Whilst the design was feasible to undertake, this trial
has highlighted a lack of clinically relevant outcome
measures, appropriate to this setting, for both research
and clinical practice. Many older adults consider func-
tional independence to be more important than the pre-
vention of disease [81, 82], which supports the use of a
measure of functional effects as a primary outcome for a
future malnutrition intervention trial. This trial identi-
fied a need for a more simple measure of functional sta-
tus, which considers the impediments of functional tests
in the care home population. Further qualitative research
may be required to explore the nutritional and clinical pri-
orities of those working and residing in the care home
setting, alongside the perceived value of nutritional inter-
ventions. The results could be interpreted alongside the
feasibility outcomes to provide an enhanced understanding
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of the nutritional care complexities within care homes and
to further inform the design of a definitive trial and choice
of primary outcome measure.
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